Whitepaper

Current Treatment Challenges of IO Refractory Patients and Clinical Development of Therapies Targeting These Patients
Harnessing the power of own immune cells, Immuno-oncology therapies are carving out a nice in oncology treatment landscape
Current Treatment Challenges of IO Refractory Patients and Clinical Development of Therapies Targeting These Patients

More Whitepapers / Newsletters

Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of Pulmonary Hypertension, delineated by the elevated pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in...

Future of Medical Imaging
Future of Medical Imaging

The medical device industry is experiencing rapid change as innovation is accelerating, new business models are evolving, and artificial intelligence and the Internet of Things generate transformative health care possibilities...

Hospital-acquired bacterial pneumonia/ Ventilator-associated bacterial pneumonia Newsletter
Hospital-acquired bacterial pneumonia/ Ventilator-associated bacterial pneumonia

Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care...

Chronic Pancreatitis
Chronic Pancreatitis

Chronic Pancreatitis is an inflammation of the pancreas that can be a result of calcium stones and cysts, acute inflammation, cystic fibrosis, unhealthy lifestyle habits, certain autoimmune disorders or due to hereditary diseases...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males..